Crohn's Disease and Adalimumab

Links shared publicly online about this topic

NICE Recommends Infliximab And Adalimumab For The Treatment Of Severe, Active Crohn's Disease

medicalnewstoday.com — “In final draft guidance published today (4 March) NICE has recommended infliximab and adalimumab as treatment options for people with severe, active Crohn's disease whose condition has not respondView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 5, 2010 at 4:37 am By:

medical_tweets medical_tweets Health News

NICE Recommends Infliximab And Adalimumab For The Treatment Of Severe, Active Crohn's Disease In final draft guidance.. http://bit.ly/cAsG7S

2 years ago...

Adalimumab Sustains Remission for Crohn's Disease - QualityPoint Technologies

qualitypointtech.net — “Steroids can often cause serious side effects in Crohn's disease patients over time. What other therapies are available instead? Alimentary Pharmacology & TherapeuticsView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on August 31, 2011 at 12:45 pm By:

MedicalFeed MedicalFeed Health News Feed

Adalimumab Sustains Remission for Crohn's Disease: Steroids can often cause serious side effects in Crohn's dise... http://t.co/tLuRyoP

9 months ago...

Pulmonary carcinoid tumor in a patient on adalimumab for Crohn's disease - Betteridge - 2012 - Inflammatory Bowel Diseases - Wiley Online Library

onlinelibrary.wiley.com — “Pulmonary carcinoid tumor in a patient on adalimumab for Crohn's disease - Betteridge - 2012 - Inflammatory Bowel Diseases - Wiley Online LibraryView full resource at onlinelibrary.wiley.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 7:44 am By:

CrohnDisease Crohn Disease Wisdom OW Health

Pulmonary carcinoid tumor in a patient on adalimumab for Crohn's disease: (Source: Inflammatory Bowel Diseases)M... http://t.co/fak8LtK5

2 months ago...

NICE recommends infliximab and adalimumab for Crohn's disease treatment | News | Nursing Times

nursingtimes.net — “In final draft guidance published today (4 March) NICE has recommended infliximab and adalimumab as treatment options for people with severe, active Crohn's disease whose condition has not responded to conventional therapy, or who are intolerant of or have contraindications to conventional therapy.View full resource at nursingtimes.net

  • View Related
  • Share

Most Recently Shared on March 4, 2010 at 11:55 am By:

NursingTimes Nursing Times Health Magazine

News: NICE recommends infliximab and adalimumab for Crohn's disease treatment http://bit.ly/dvpjj3

2 years ago...

Gastroenterology News - Long-term durability of response to adalimumab in Crohns disease |3966581

mdlinx.com — “Gastroenterology Medical Article: Long-term durability of response to adalimumab in Crohns diseaseView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 2:08 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Long-term durability of response to adalimumab in Crohns disease: Inflammatory Bowel Disease http://t.co/38Jf2LQ5 #GI

2 months ago...

Adalimumab - An Effective and Promising Treatment for Patients With Fistulizing Crohn's Disease: A Case Series - QualityPoint Technologies

qualitypointtech.net — “Adalimumab, a fully human anti-tumor necrosis factor monoclonal antibody, has been suggested as a safe and effective treatment in fistulizing Crohn's disease. How effective was it in these patients? Journal of Medical Case ReportsView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on June 1, 2011 at 1:00 pm By:

MedicalFeed MedicalFeed Health News Feed

Adalimumab - An Effective and Promising Treatment for Patients With Fistulizing Crohn's Disease: A Case Series: A... http://bit.ly/k6bfby

12 months ago...

Gastroenterology Article | Switch to adalimumab in patients with Crohns disease controlled by maintenance infliximab: prospective randomised SWITCH trial

mdlinx.com — “Switch to adalimumab in patients with Crohns disease controlled by maintenance infliximab: prospective randomised SWITCH trialView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on October 10, 2011 at 11:28 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Switch to adalimumab in patients with Crohns disease controlled by maintenance infliximab: prospective rando... http://t.co/AZ3F6oEe #GI

8 months ago...

Crohn Disease on #MDlinx

mdlinx.com — “Crohn Disease on #MDlinxView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 30, 2010 at 2:41 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity... http://bit.ly/bGhqzR #medicine

2 years ago...

Gastroenterology Article | Crohn Disease

mdlinx.com — “Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trialView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on August 9, 2011 at 12:44 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: Results of t... http://bit.ly/neK5CB #GI

10 months ago...

Family Medicine Article | Crohn Disease

mdlinx.com — “Development of the Nephrotic Syndrome During Treatment of Crohns Disease With AdalimumabView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on February 11, 2011 at 12:40 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Development of the Nephrotic Syndrome During Treatment of Crohns Disease With Adalimumab: Journal o... http://bit.ly/g18IuO #FamPractice

1 year ago...

Crohn's Disease

medicinenet.com — “Learn about Crohn's Disease and the causes, symptoms (including abdominal pain, diarrhea, weight loss, fever, rectal bleeding, and more) and treatment of this chronic inflammatory disease of the intestines.View full resource at medicinenet.com

  • View Related
  • Share

Most Recently Shared on November 10, 2009 at 11:49 pm By:

Family Medicine Article | Crohn Disease

mdlinx.com — “Survey on the use of adalimumab as maintenance therapy in Crohn's disease in England and IrelandView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on November 18, 2010 at 8:28 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Survey on the use of adalimumab as maintenance therapy in Crohn's disease in England and Ireland: E... http://bit.ly/coFXHe #FamPractice

2 years ago...

Gastro Medical News about Crohn Disease

mdlinx.com — “Adalimumab for Crohn's disease in clinical practice at Mayo clinic: The first 118 patientsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 5, 2010 at 4:21 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Adalimumab for Crohn's disease in clinical practice at Mayo clinic: The first 118 patients: Inflammatory Bowel ... http://bit.ly/97ye4D #GI

2 years ago...

Family Medicine Article | Crohn Disease

mdlinx.com — “Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trialView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on August 9, 2011 at 6:41 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: Res... http://bit.ly/qAvwO8 #FamPractice

10 months ago...

Gastro Medical News about Crohn Disease

mdlinx.com — “Risk-benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's diseaseView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 3, 2010 at 11:20 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Risk-benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's disease... http://bit.ly/aAqAkz #GI

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390